1-2 of 2
Keywords: Real-world data
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Fedratinib in Routine Treatment of Ruxolitinib-Resistant or -Refractory Patients with Primary and Post-Polycythemia Vera or Essential Thrombocythemia Myelofibrosis: A Nationwide Retrospective Study

Available to Purchase
Subject Area:
Hematology , Oncology
Adrian Duek, Alexandra Tzinman, Kira Maziuk, Assaf Levy, Martin Ellis, Galia Stemer, Adi Shacham Abulafia, Amos Cohen, Noa Lavi, Aaron Ronson, Andrey Braester, Shirley Shapira, Jonathan Canaani, Yulia Volchek, Ronit Leiba, Merab Leiba
Journal: Acta Haematologica
Acta Haematol 1–7.
https://doi.org/10.1159/000540906
Published Online: 12 September 2024
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Fedratinib Myelofibrosis Real-world data Primary myelofibrosis (PMF) is a rare and debilitating myeloproliferative neoplasm...
View articletitled, Outcomes of Fedratinib in Routine Treatment of Ruxolitinib-Resistant or -Refractory Patients with Primary and Post-Polycythemia Vera or Essential Thrombocythemia Myelofibrosis: A Nationwide Retrospective Study
Open the PDF for Outcomes of Fedratinib in Routine Treatment of Ruxolitinib-Resistant or -Refractory Patients with Primary and Post-Polycythemia Vera or Essential Thrombocythemia Myelofibrosis: A Nationwide Retrospective Study in another window
Journal Articles

Racial and Ethnic Characteristics and Outcomes of Patients Diagnosed with CLL/SLL in the USA

Open Access
Subject Area:
Hematology , Oncology
Debora S. Bruno, Manoj Khanal, Xiaohong I. Li, Maricer P. Escalon, Katherine B. Winfree, Lisa M. Hess
Journal: Acta Haematologica
Acta Haematol (2025) 148 (2): 148–162.
https://doi.org/10.1159/000538836
Published Online: 20 May 2024
.... Real-world data Healthcare disparities BTKi therapy Survival Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL, hereafter CLL) is a cancer that is most commonly diagnosed among patients of White race in the USA. According to Surveillance, Epidemiology and End Results (SEER...
View articletitled, Racial and Ethnic Characteristics and Outcomes of Patients Diagnosed with CLL/SLL in the USA
Open the PDF for Racial and Ethnic Characteristics and Outcomes of Patients Diagnosed with CLL/SLL in the USA in another window